Bristol-Myers Squibb

Member of UN Global Compact

Headquarters in USA

Bristol-Myers Squibb website

🔎 Run a search for “Bristol-Myers Squibb”

Get RSS feed of these results

All stories

Story
14 November 2011

India: Pharmaceutical firms allegedly violated intl. ethical standards when they funded clinical trials on survivors of Bhopal gas tragedy

See full story

Article
14 November 2011

Without consent: how drugs companies exploit Indian 'guinea pigs'

Author: Andrew Buncombe & Nina Lakhani, Independent [UK]

Western pharmaceutical companies have seized on India over the past five years as a testing ground for drugs – making the most of…loose regulations which help dramatically cut research costs…Between 2007 and 2010, at least 1,730 people died in India...

Read more

Article
28 June 2011

Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz(R) (atazanavir sulfate) in sub-Saharan Africa and India

Author: Bristol-Myers Squibb

Bristol-Myers Squibb announced a new agreement to expand access to Reyataz(R) (atazanavir sulfate). The immunity-from-suit agreement signed with Matrix Laboratories...enables the generic company to manufacture and sell atazanavir, as well as stavudine...

Read more

Article
6 May 2011

Special report: Big Pharma's global guinea pigs

Author: Ben Hirschler, Reuters

[T]he clinical trials business has gone global as drugmakers seek cheaper venues for studies…The increasing reliance on clinical trials in Eastern Europe, Asia and Latin America raises serious questions…are ethical standards in testing new drugs...

Read more

Article
1 February 2011

[PDF] Putting Contract Research Organisations on the Radar: An exploratory study on the outsourcing of clinical trials by pharmaceutical companies to contract research organisations in non-traditional trial regions

Author: Mariëtte van Huijstee & Irene Schipper, SOMO, Salud y Fármacos, Centre for Studies in Ethics and Rights

The ultimate goal of this study is to persuade all the actors…to take responsibility to protect the human rights of clinical trial participants in non-traditional trial regions…[A]ccording to international regulations, pharmaceutical companies remain...

Read more

Story
8 December 2010

Report examines role of business-driven partnerships in addressing sustainable development in Africa - includes case studies

See full story

Article
8 December 2010

[PDF] Full report: "Business Partnerships for Development in Africa"

Author: Business Action for Africa & Corporate Social Responsibility Initiative at Harvard Kennedy School

...Business Action for Africa’s 2010 Report...examines how business-driven partnerships are addressing Africa’s development challenges in new and innovative ways… creating new frontiers for sustainable development and growth on the continent...the...

Read more

Article
16 September 2010
+ Español - Hide

Author: Europa Press [España]

La farmacéutica Bristol-Myers Squibb (BMS) ha lanzado una campaña de concienciación con la que pretenden alertar de las conductas de riesgo que favorecen el contagio de hepatitis B y explicar las consecuencias que puede tener un diagnóstico tardío de...

Read more

Article
31 August 2010

[PDF] Carbon Disclosure Project 2010 Global 500 Report

Author: PriceWaterhouseCoopers, Carbon Disclosure Project

In 2010, the CDP asked the world’s 500 largest public companies in the FTSE Global Equity Index Series...to demonstrate that they are taking action on climate change. This report, prepared by CDP’s global adviser, PricewaterhouseCoopers (PwC),...

Read more

Article
26 July 2010

Bristol-Myers Squibb Foundation combats HIV and tuberculosis in African community projects

Author: MTB Europe

Bristol-Myers Squibb Company and the Bristol-Myers Squibb Foundation announced at the XVIII International AIDS Conference in Vienna the community-based projects that it is currently supporting in resource-poor regions across Africa to help combat the...

Read more